...
首页> 外文期刊>Breast Cancer Research and Treatment >Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway
【24h】

Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway

机译:来自原发性乳腺癌组织的间充质干细胞通过EGF / EGFR / Akt途径部分促进癌症扩散并增强乳球形成

获取原文
           

摘要

Mesenchymal stem cells (MSCs) play a critical role in promoting cancer progression. However, it is not clear whether MSCs are located in breast cancer tissues and correlated with tumor proliferation. The aim of this study was to investigate the presence of MSCs in breast cancer tissues and evaluate their interactions with cancer cells. We successfully isolated and identified MSCs from primary breast cancer tissues. Breast cancer-associated MSCs (BC-MSCs) showed homogenous immunophenotype, and possessed tri-lineage differentiation potential (osteoblast, adipocyte, and chondrocyte). When co-transplanted with cancer cells in a xenograft model in vivo, BC-MSCs significantly increased the volume and weight of tumors. We observed that BC-MSCs stimulated mammosphere formation in the transwell co-culture system in vitro. This effect was significantly suppressed by the EGF receptor inhibitor. We verified that BC-MSCs could secrete EGF and activate cancer cell’s EGF receptors. Furthermore, our data showed that EGF derived from BC-MSCs could promote mammosphere formation via the PI3K/Akt signaling pathway. Our results confirmed the presence of MSC in primary breast cancer tissues, and they could provide a favorable microenvironment for tumor cell growth in vivo, partially enhance mammosphere formation via the EGF/EGFR/Akt pathway.
机译:间充质干细胞(MSC)在促进癌症进展中起关键作用。然而,尚不清楚MSC是否位于乳腺癌组织中并与肿瘤增殖相关。这项研究的目的是调查乳腺癌组织中MSC的存在并评估它们与癌细胞的相互作用。我们成功地从原发性乳腺癌组织中分离并鉴定了MSC。乳腺癌相关的MSC(BC-MSC)显示出均一的免疫表型,并具有三系分化潜能(成骨细胞,脂肪细胞和软骨细胞)。当在体内异种移植模型中与癌细胞共移植时,BC-MSC显着增加了肿瘤的体积和重量。我们观察到,BC-MSCs在体外transwell共培养系统中刺激了乳球形成。该作用被EGF受体抑制剂显着抑制。我们验证了BC-MSC可以分泌EGF并激活癌细胞的EGF受体。此外,我们的数据表明,源自BC-MSC的EGF可通过PI3K / Akt信号通路促进乳球形成。我们的结果证实了MSC在原发性乳腺癌组织中的存在,它们可以为体内肿瘤细胞的生长提供有利的微环境,并通过EGF / EGFR / Akt途径部分增强乳腺球的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号